Your browser doesn't support javascript.
loading
Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis.
Edwards, Camille Vanessa; Rao, Nisha; Bhutani, Divaya; Mapara, Markus; Radhakrishnan, Jai; Shames, Sofia; Maurer, Mathew S; Leng, Siyang; Solomon, Alan; Lentzsch, Suzanne; Eisenberger, Andrew.
Afiliación
  • Edwards CV; Division of Hematology/Oncology.
  • Rao N; Department of Internal Medicine.
  • Bhutani D; Division of Hematology/Oncology.
  • Mapara M; Division of Hematology/Oncology.
  • Radhakrishnan J; Division of Nephrology, and.
  • Shames S; Division of Cardiology, Columbia University Medical Center,  New York, NY; and.
  • Maurer MS; Division of Cardiology, Columbia University Medical Center,  New York, NY; and.
  • Leng S; Division of Hematology/Oncology.
  • Solomon A; Graduate School of Medicine, University of Tennessee, Knoxville, TN.
  • Lentzsch S; Division of Hematology/Oncology.
  • Eisenberger A; Division of Hematology/Oncology.
Blood ; 138(25): 2632-2641, 2021 12 23.
Article en En | MEDLINE | ID: mdl-34521113
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Anticuerpos Monoclonales Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Anticuerpos Monoclonales Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article